Gao et al found that CD24+ CSC cells were relatively quiescent and enriched at the S phase, leading to the chemotherapeutic resistance to cisplatin treatment compared with CD24− OC cells from human ovarian tumor specimens [55]. Here, CD24 is linked to ovarian neoplasm.